Optimer Spells Out Plans For Further Dificid Penetration
This article was originally published in The Pink Sheet Daily
Executive Summary
Optimer Pharmaceuticals outlined its commercial strategy for recently launched antibiotic Dificid. The company plans to concentrate on long-term care facilities and proving that the drug is preferable over potential generic competition.